Paul F. Kantor

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary

Steve R. Ommen, Seema Mital, Michael A. Burke et al. · Journal of the American College of Cardiology · 2020 · 983 citations

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +8

The Antianginal Drug Trimetazidine Shifts Cardiac Energy Metabolism From Fatty Acid Oxidation to Glucose Oxidation by Inhibiting Mitochondrial Long-Chain 3-Ketoacyl Coenzyme A Thiolase

Paul F. Kantor, Arnaud Lucien, Raymond Kozak et al. · Circulation Research · 2000 · 802 citations

Heart Failure, Lipid Peroxidation, Metabolic Remodeling +17

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

Steve R. Ommen, Seema Mital, Michael A. Burke et al. · Journal of the American College of Cardiology · 2020 · 651 citations

Cardiomyopathy, Structural Heart Disease, Cardiovascular Disease +6

Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

Ray E. Hershberger, Michael M. Givertz, Carolyn Y. Ho et al. · Genetics in Medicine · 2018 · 273 citations · Full text

Cardiomyopathy, Cardiovascular Disease, Genetics +9

Presentation, Diagnosis, and Medical Management of Heart Failure in Children: Canadian Cardiovascular Society Guidelines

Paul F. Kantor, Jane Lougheed, Adrian Dancea et al. · Canadian Journal of Cardiology · 2013 · 256 citations

Family Medicine, Heart Failure, Cardiovascular Disease +8